Ranibizumab ophthalmic and Voltaren Ophthalmic
Determining the interaction of Ranibizumab ophthalmic and Voltaren Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: diclofenac ophthalmic
Brand name: Voltaren Ophthalmic
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Voltaren Topical
- Ranibizumab ophthalmic-Voltaren-XR
- Ranibizumab ophthalmic-Von Willebrand Factor
- Ranibizumab ophthalmic-Von Willebrand factor recombinant
- Ranibizumab ophthalmic-Von willebrand factor recombinant Intravenous
- Ranibizumab ophthalmic-Vonvendi
- Voltaren Ophthalmic-Ranitidine
- Voltaren Ophthalmic-Ranitidine Capsule
- Voltaren Ophthalmic-Ranitidine Hydrochloride
- Voltaren Ophthalmic-Ranitidine Injection
- Voltaren Ophthalmic-Ranitidine Suspension
- Voltaren Ophthalmic-Ranitidine Syrup